Advisory Services Network, LLC Bausch Health Companies Inc. Transaction History

Advisory Services Network, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$6.53 - $8.23 $6,530 - $8,230	1,000 New	1,000 $8,000
Q1 2023 May 17, 2023	SELL	$6.28 - $9.85 $1,350 - $2,117	-215 Reduced 12.54%	1,500 $12,000
Q4 2022 Feb 13, 2023	SELL	$6.09 - $7.93 $154,077 - $200,629	-25,300 Reduced 93.65%	1,715 $10,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $79,921 - $160,714	-17,450 Reduced 39.24%	27,015 $186,000
Q2 2022 Aug 02, 2022	BUY	$7.06 - $23.63 $313,922 - $1.05 Million	44,465 New	44,465 $372,000
Q3 2021 Nov 05, 2021	SELL	$25.04 - $30.06 $91,396 - $109,719	-3,650 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$27.43 - $32.7 $100,119 - $119,355	3,650 New	3,650 $107,000
Q1 2021 May 24, 2021	SELL	$21.37 - $34.38 $65,178 - $104,859	-3,050 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$15.31 - $21.12 $7,455 - $10,285	-487 Reduced 13.77%	3,050 $63,000
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $104,487 - $141,352	-7,022 Reduced 66.5%	3,537 $55,000
Q2 2020 Aug 10, 2020	BUY	$13.31 - $20.51 $140,540 - $216,565	10,559 New	10,559 $193,000
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $1,298 - $3,025	-100 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$18.89 - $31.89 $16,037 - $27,074	-849 Reduced 89.46%	100 $3,000
Q2 2019 Aug 01, 2019	SELL	$20.52 - $26.45 $362,198 - $466,868	-17,651 Reduced 94.9%	949 $0
Q1 2019 May 20, 2019	BUY	$20.23 - $26.29 $40,965 - $53,237	2,025 Added 12.22%	18,600 $459,000
Q4 2018 Feb 15, 2019	SELL	$17.64 - $28.32 $68,213 - $109,513	-3,867 Reduced 18.92%	16,575 $306,000
Q3 2018 Nov 02, 2018	BUY	$20.64 - $25.67 $421,922 - $524,746	20,442 New	20,442 $525,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.